COVID Delta is raging: 4 ASX shares to buy in turbulent times

The coronavirus and lockdowns are making a roaring comeback in 2021. So which stocks are reliable in such turbulent times?

| More on:
A woman kicks a giant COVID-19 molecule, indicating positive share price movement for biotech companies

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Both the Australian and US share markets have been a bit nervous in recent weeks about the Delta variant of COVID-19.

After first devastating India, this strain of the coronavirus has since impacted the entire globe. Even Australia, with its strict borders, could not keep it out — and now half the population is under lockdown.

This health crisis has put a nasty spanner in the post-pandemic economic recovery narrative.

Unfortunately, the market is "on tenterhooks" because of Australia's low vaccination rate, according to Montgomery Investment Management chief investment officer Roger Montgomery.

"The Delta variant is materially more infectious than the original COVID-19 strain and is now the dominant strain in Australia," he said on the company blog.

"And, importantly, with half of winter remaining, the lack of a broadly vaccinated population presents the virus with an opportunity to mutate, potentially undermining the efficacy of current vaccines."

So what to do now for share investors?

Back to lockdown-friendly ASX shares

This means that more lockdowns seem to be inevitable for the rest of the year. So Montgomery reckons it's time to flee back to the stocks that led the way in April last year.

"Lockdowns must necessarily shift spending from services and experiences (that were available in open cities) to online spending on goods," he said.

"Online shopping spiked during the last 12 to 18 months, and as consumers returned to in-store shopping, online eased. This could rapidly reverse with only essential stores permitted to open."

Montgomery added that retailers that sell homewares and appliances could do especially well.

"Harvey Norman Holdings Limited (ASX: HVN), JB Hi-Fi Limited (ASX: JBH), Nick Scali Limited (ASX: NCK), Adairs Ltd (ASX: ADH) were huge beneficiaries during last year's lockdowns. And amid the recent easing of restrictions they continued to win."

He did warn, though, that durable goods like large appliances have long lives. So the rate of sales growth might not be quite as spectacular as last year.

ASX shares related to hospitals, raw materials, energy and building materials all did well in the "re-opening" trade, but would now stumble.

"It should not be surprising, in such circumstances, to see at least some capital reallocated from profitable reopeners to lockdown winners," said Montgomery.

"The key question for investors to now consider, however, is whether a reopening is undermined by a new strain of the virus that evades vaccines."

Even vaccinated populations are struggling

Montgomery pointed out that even countries with high rates of COVID vaccination still struggled with Delta.

"In just the last month, the Netherlands, with more than three quarters of the population vaccinated, suffered the devastating effects of reopening too quickly," he said. 

"Infections rose more than 500% in just one week. Shortly after the Dutch caretaker prime minister, Mark Rutte, announced that face masks would no longer be required, the Dutch government started backtracking on restrictions."

A glass-half full view of the Delta strain slowing the share market is that inflation worries could subside. 

This would result in more dovish central banks, keeping interest rates at near historic lows.

"The emergence of the highly infectious Delta variant makes the future far less certain," said Montgomery.

"My take is that higher quality and structural growth businesses should again be on your radar."

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ADAIRS FPO. The Motley Fool Australia owns shares of and has recommended ADAIRS FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Coronavirus News

Man with his hand on his face looking at a falling share price chart on a tablet.
Share Market News

ASX 200 stocks dive 2.4% in worst trading day since Ukraine crisis hit

It's not a good start to the week for the market.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand. representing the falling Air New Zealand share price today
Travel Shares

Borders just reopened so why is the Flight Centre (ASX:FLT) share price falling today?

Experts believe it may take several years for tourism levels to rebound to pre-pandemic numbers.

Read more »

A worker in hi vis gear holds his hand up saying no.
Coronavirus News

Own BHP (ASX:BHP) shares? Here's how the ASX 200 miner is battling COVID

Mining unions have not generally supported mandatory vaccinations.

Read more »

Female worker sitting desk with head in hand and looking fed up
Coronavirus News

Here's what Rio Tinto (ASX:RIO) boss says is 'causing some challenges' right now

The Omicron variant is spreading in Western Australia.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Coronavirus News

Why are ASX COVID test shares climbing today?

COVID-19 tests are in focus again today.

Read more »

a girl stands in an apple orchard holding two red apples in raised arms with a happy, celebratory look on her face with a large smile and a pretty country background to the picture.
Economy

CBA reveals the Australian economy's leading state amid COVID surge

The states and territories have all been impacted by the pandemic.

Read more »

Rapid Antigen Test taking place.
Share Market News

Why is Ellume hitting headlines today?

Brisbane-based diagnostics developer Ellume is back in the headlines.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Share Market News

Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

Read more »